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It has been increasingly recognized by universities, journals’ editors and, 
probably in a less degree, by publishers, that there is a crisis in science1,2. 
This is so important that, the Editor-in-Chief of Lancet, Richard Horton, has 
recently stated that “much of the scientific literature, perhaps half, may simply 
be untrue1.”
There are many issues surrounding this matter, including clear research 
misconduct1,2, but the cornerstone of the crisis is the quality of the research 
that has been currently published, and this comprises poor clarity in methods, 
notoriously biased results, and obviously invalid conclusions1-3.
It is well known that our scientific culture privileges quantity over quality, but 
it seems that this practice ultimately resulted in an “endemicity of bad research 
behavior”1. It seems that this culture has been developed at the same pace of 
the widespread of the science. Science is no longer for a few. The increasing 
competition among research institutions, mostly universities, and researchers, 
for financial support for their work, among other things, has led the system to 
develop an objective way to distinguish who should be encouraged to go further 
through financial and other specific kinds of support. Indeed, it is unrealistic 
to think about research nowadays without metrics. So far, the most objective 
(I do not mean the best) way to assess science is quantitatively. Not only by 
the number of publications, but also through a quantification of the impact 
of the research by the h-index, for example. Both are necessary but both 
have flaws. Moreover, what is the price scientists should pay for having the 
combination of a reasonable number of publications and, possibly, at least 
statistically, a greater number of citations? I think no one knows exactly, but 
what we are seeing, as underscored by editors of core scientific journals, is 
that the price has been a low quality research.
Obviously, researchers publish studies not only for more financial 
support, prestige or influence, and we are not talking about only publishing 
“revolutionary” scientific findings. The “nature does not make leaps”. Neither 
does science. The great “discoveries” are, in fact, the pinnacle of a long road 
of many smaller findings that allowed the progress of not only science per se 
but ultimately human knowledge as well. So, we need research. All kinds of 
research. In fact, we are talking about quality. Transparency and reproducibility 
are the mainstream of good science2. It is not about how long you have gone, 
but about how you have gone there. And even further, have you really gone 
there? From a slightly distinct point of view or, in other words, it seems that, 
at a given moment, the major aim of scientific production was forgotten and 
“publication philosophy” became utilitarian and certainly distorted.
However, where is the editors’ responsibility? Which are their faults? 
As stated in a recent editorial from Nature, “eradicating misconduct is 
difficult. It demands cultural change, education and a system of checks and 
balances4.” Nonetheless, a more rigorous assessment of the quality of the 
basic structure of a scientific investigation, particularly the methods, which are 
the tools used to reach a given conclusion, has been somewhat abandoned 
by those who choose what should and should not be published. Furthermore, 
even if reasonably described, there are many misleading conclusions raised 
from arguable results that have not been thoughtfully addressed by peer 
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reviewers, which are commonly not fully prepared 
for the evaluation of research procedures, including 
epidemiological and statistical methods. The recognition 
of the problem is quite important but it is still not 
clear how to circumvent such situation. As said by 
Richard Horton, “The good news is that science 
is beginning to take some of its worst failings very 
seriously. The bad news is that nobody is ready to 
take the first step to clean up the system1.”
Finally, what is the role of new or emerging 
scientific journals, such as Clinical and Biomedical 
Research, which aim for recognition and want to 
publish and be cited? Certainly, it is advisable not 
to repeat past errors, i.e. these journals should 
not publish bad quality research. However, at this 
point, if poor science has been published in major 
journals, what one could expect to be published in 
smaller, new and/or emerging journals? The answer 
is easy: bad science does not mean low impact 
results or results that are too far from “revolutionary”. 
It is the role of emerging journals to educate and 
uphold researchers to aspire for and to preserve 
the main structure of the scientific method, clarity 
and reproducibility, which will determine valid results 
and make clear the limitations of the investigations. 
Even for simple research questions, if the bases 
are not conserved, the results, regardless of their 
impact in science and society, will be untrue, and 
this may be a silent way to put forward the crisis 
in science.
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